Largest biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 biotech companies ranked by total assets, at CZK 2.01T, ahead of Gilead Sciences (CZK 1.31T) and Biogen (CZK 654.8B). Figures as of 18 Nov 2026, 19:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenCZK 2.01T
- Median
- CZK 56.9B
- Combined market value
- CZK 18.6T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | CZK 2.01T | CZK 5.33T | CZK 9,845.57 | 3.34% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | CZK 1.31T | CZK 4.65T | CZK 3,745.82 | 1.09% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | CZK 654.8B | CZK 823.4B | CZK 5,570.24 | 0.15% down | 49% up | ||
| 4 | BioNTechBNTX · Health Care | CZK 542.7B | CZK 461.2B | CZK 1,860.34 | 1.44% down | 16% down | ||
| 5 | ModernaMRNA · Health Care | CZK 274.4B | CZK 1.79T | CZK 4,429.81 | 3.70% down | 755% up | ||
| 6 | argenxARGX · Health Care | CZK 193.1B | CZK 1.32T | CZK 21,015.53 | 0.29% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | CZK 139.7B | CZK 228.2B | CZK 1,105.06 | 0.14% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | CZK 103B | CZK 367.5B | CZK 3,630.82 | 1.62% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | CZK 66.8B | CZK 205.4B | CZK 1,297.47 | 1.80% down | 22% up | ||
| 10 | RepligenRGEN · Health Care | CZK 65.6B | CZK 242.9B | CZK 3,799.87 | 5.33% up | 5% up | ||
| 11 | ExelixisEXEL · Health Care | CZK 63.3B | CZK 372.8B | CZK 1,527.91 | 0.28% up | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | CZK 57.5B | CZK 254.3B | CZK 1,618.78 | 0.20% up | 26% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | CZK 56.2B | CZK 244.3B | CZK 2,142.95 | 0.39% up | 37% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | CZK 52.4B | CZK 771.8B | CZK 3,568.54 | 1.39% down | 131% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | CZK 50.4B | CZK 88.3B | CZK 910.43 | 1.94% up | 21% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | CZK 38.8B | CZK 230.7B | CZK 2,702.82 | 0.01% down | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | CZK 29.7B | CZK 206.4B | CZK 6,965.81 | 4.89% up | 46% up | ||
| 18 | ImmunovantIMVT · Health Care | CZK 21.3B | CZK 153.2B | CZK 740.04 | 0.18% up | 43% up | ||
| 19 | CG OncologyCGON · Health Care | CZK 17.6B | CZK 157.7B | CZK 1,765.03 | 0.52% up | 85% up | ||
| 20 | Twist BioscienceTWST · Health Care | CZK 14.3B | CZK 179B | CZK 2,625.63 | 5.39% up | 340% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | CZK 11.4B | CZK 102.8B | CZK 634.83 | 0.18% up | 88% up | ||
| 22 | ImmunityBioIBRX · Health Care | CZK 11.2B | CZK 156.8B | CZK 147.36 | 5.83% up | 193% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | CZK 9B | CZK 129.2B | CZK 1,059.24 | 5.63% up | 14% up | ||
| 24 | Kodiak SciencesKOD · Health Care | CZK 7.8B | CZK 141B | CZK 2,155.63 | 0.11% up | 396% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2436 CZK).
Questions and answers
Which biotech companies rank first by total assets?
Amgen (CZK 2.01T), Gilead Sciences (CZK 1.31T) and Biogen (CZK 654.8B) are the top three of the 24 biotech companies ranked by total assets as of 18 Nov 2026, 19:23 UTC.
How many biotech companies are in this ranking?
24 are ranked by total assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by total assets have a combined market value of CZK 18.6T as of 18 Nov 2026, 19:23 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.